Quality by design driven RP-HPLC method optimization for analysis of levothyroxine and liothyronine in bulk and tablet dosage form

Ramdas Darade; Sanjay  Pekamwar

doi:10.69857/joapr.v13i2.867

Authors

Ramdas Darade Department of Pharmaceutical Chemistry, School of Pharmacy, Swami Ramanand Teerth Marathwada University, Nanded 431606 Maharashtra, India
Sanjay Pekamwar Department of Pharmaceutical Chemistry, School of Pharmacy, Swami Ramanand Teerth Marathwada University, Nanded 431606 Maharashtra, India

DOI:

https://doi.org/10.69857/joapr.v13i2.867

Keywords:

Levothyroxine, Liothyronine, RP HPLC, Quality by Design, Method Development

Abstract

Background: Levothyroxine and Liothyronine are widely used in thyroid hormone replacement therapies. Simultaneously quantifying Levothyroxine and Liothyronine is important for managing thyroid hormone deficiency. Aim: This study aims to develop and validate an accurate and robust RP-HPLC method for simultaneously quantifying Levothyroxine and Liothyronine by utilizing Quality by Design (QbD). Methodology: Reversed phase chromatography was performed using a High Performance Liquid Chromatographic System (Agilent Technologies Ltd, 1100 series) equipped with a UV detector. The column used was Agilent C 18 (100 mm x 4.6 mm; 5µm) HPLC Column. The chromatographic separation was carried out using a mobile phase composed of Methanol and Formic acid (0.1%) (50:50 %v/v) with a flow rate of 1.2 ml/min, and a UV detector recorded the response at 254 nm. Design expert was used as software to evaluate experimental design studies (Stat-Ease Inc., Minneapolis, USA, Version 13.0). Result and Discussion: The RP-HPLC method was established to quantify Levothyroxine and Liothyronine simultaneously. The established method was linear, and correlation coefficients (R²) were 0.9993 and 0.9994 for Levothyroxine and Liothyronine, respectively. Retention times of Levothyroxine and Liothyronine were 2.587 minutes and 3.035 minutes. Results of accuracy, precision studies, LOD, and LOQ were found within acceptable limits. Conclusion: A robust RP-HPLC method was developed for the simultaneous quantification of levothyroxine and liothyronine by utilizing a QbD. The QbD technique provided a systematic methodology for identifying and optimizing the critical parameters influencing the method's performance.

Downloads

Download data is not yet available.

References

Agarwal A, Asif M, Deshmukh R, Vinchurkar M, Singana SB, Bhondave P. Preclinical toxicological assessment of levothyroxine and liothyronine Maillard impurities. Toxicol Res (Camb), 11, 743–9 (2022) https://doi.org/10.1093/toxres/tfac047.

Yamauchi K. 3,3′,5-Triiodothyronine. Handbook of Hormones. Elsevier, pp. 891–4 (2021). https://doi.org/10.1016/B978-0-12-820649-2.00245-X

Beynon ME, Pinneri K. An Overview of the Thyroid Gland and Thyroid-Related Deaths for the Forensic Pathologist. Acad Forensic Pathol, 6, 217–36 (2016) https://doi.org/10.23907/2016.024.

De Leo S, Lee SY, Braverman LE. Hyperthyroidism. The Lancet, 388, 906–18 (2016) https://doi.org/10.1016/S0140-6736(16)00278-6.

Unnikrishnan A, Menon U. Thyroid disorders in India: An epidemiological perspective. Indian J Endocrinol Metab, 15, 78 (2011) https://doi.org/10.4103/2230-8210.83329.

Leso V, Vetrani I, De Cicco L, Cardelia A, Fontana L, Buonocore G, Iavicoli I. The Impact of Thyroid Diseases on the Working Life of Patients: A Systematic Review. Int J Environ Res Public Health, 17, 4295 (2020) https://doi.org/10.3390/ijerph17124295.

Yamakawa H, Kato TS, Noh JY, Yuasa S, Kawamura A, Fukuda K, Aizawa Y. Thyroid Hormone Plays an Important Role in Cardiac Function: From Bench to Bedside. Front Physiol, 12, (2021) https://doi.org/10.3389/fphys.2021.606931.

Koyyada A, Orsu P. Role of hypothyroidism and associated pathways in pregnancy and infertility: Clinical insights. Tzu Chi Med J, 32, 312 (2020) https://doi.org/10.4103/tcmj.tcmj_255_19.

Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid, 24, 1670–751 (2014) https://doi.org/10.1089/thy.2014.0028.

Mandić-Kovačević N, Kasagić-Vujanović I, Popović Bijelić A. Analysis of Fixed-Dose Combination of Three Antihypertensive Drugs by a Green and Quality by Design Approach. J Chromatogr Sci, 61, 256–68 (2023) https://doi.org/10.1093/chromsci/bmac044.

Soni K, Agrawal GP. Simultaneous determination of levothyroxine and its metabolite liothyronine in human serum by using LC-ESI-MS/MS and its bioequivalence application. J Appl Pharm Sci, 14(11), 178-188 (2024) https://doi.org/10.7324/JAPS.2024.187582.

Permana AD, Stewart SA, Domínguez-Robles J, Amir MuhN, Bahar MuhA, Donnelly RF, Larraneta E. Development and validation of a high-performance liquid chromatography method for levothyroxine sodium quantification in plasma for pre-clinical evaluation of long-acting drug delivery systems. Analytical Methods, 13, 5204–10 (2021) https://doi.org/10.1039/D1AY01049B.

Tricht E van, Sänger - van de Griend CE. A Practical Approach to Implementing ICH Q14: Tools for Analytical Quality by Design in Capillary Electrophoresis Method Development. Electrophoresis, (2025) https://doi.org/10.1002/elps.8110.

Patel KY, Dedania ZR, Dedania RR, Patel U. QbD approach to HPLC method development and validation of ceftriaxone sodium. Futur J Pharm Sci, 7, 141 (2021) https://doi.org/10.1186/s43094-021-00286-4.

Gurba-Bryśkiewicz L, Maruszak W, Smuga DA, Dubiel K, Wieczorek M. Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery. Biomedicines, 11, 2752 (2023) https://doi.org/10.3390/biomedicines11102752.

Chaursiya AC, L. Dumpala R. A review on revision of ICH Q2 (R1) and New ICH Q14 Guidance. Global Journal for Pharma and Allied Sciences, 1, 1–6 (2020) https://doi.org/10.47583/gjfpas.2020.v01i06.001.

Pena-Pereira F, Tobiszewski M, Wojnowski W, Psillakis E. A Tutorial on AGREEprep an Analytical Greenness Metric for Sample Preparation. Advances in Sample Preparation, 3, 100025 (2022) https://doi.org/10.1016/j.sampre.2022.100025.